Avinger, Inc.: Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA
Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent RestenosisREDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical
Source: finanznachrichten.de